Skip to main content

DiMe Publications

AbbVie, Janssen, Novartis, Pfizer and UCB to jointly advance ‘digital’ endpoint for atopic dermatitis

Join our next project

Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients

Join the Integrated Evidence Plans project

Join us
Not today